Axcella Health Inc. (AXLA): Price and Financial Metrics


Axcella Health Inc. (AXLA): $0.68

0.05 (+7.94%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add AXLA to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

AXLA Stock Price Chart Interactive Chart >

Price chart for AXLA

AXLA Price/Volume Stats

Current price $0.68 52-week high $2.89
Prev. close $0.63 52-week low $0.16
Day low $0.61 Volume 220,919
Day high $0.68 Avg. volume 1,780,635
50-day MA $0.60 Dividend yield N/A
200-day MA $1.56 Market Cap 50.02M

Axcella Health Inc. (AXLA) Company Bio


Axcella Health Inc., a biotechnology company, researches and develops novel multifactorial interventions to support health and address dysregulated metabolism in the United States. The company develops its products based on its AXA Development Platform. It offers AXA1665 for use in treating hepatic encephalopathy; AXA1125 and AXA1957 to treat non-alcoholic fatty liver disease; AXA2678 for use in treating immobilization-induced acute muscle atrophy; and AXA4010 to target multiple biological pathways.


AXLA Latest News Stream


Event/Time News Detail
Loading, please wait...

AXLA Latest Social Stream


Loading social stream, please wait...

View Full AXLA Social Stream

Latest AXLA News From Around the Web

Below are the latest news stories about AXCELLA HEALTH INC that investors may wish to consider to help them evaluate AXLA as an investment opportunity.

Biotech Stock Roundup: BLUE Down on Share Issuance, CPRX Falls on Generic Filing & More

Updates from bluebird (BLUE) and Catalyst Pharmaceuticals (CPRX) are the key highlights from the biotech sector during the past week.

Yahoo | January 25, 2023

With lean staff, low cash, Axcella races ahead with Long Covid drug

Axcella Therapeutics Inc. has one of the most advanced potential drugs for Long Covid in the industry. It also has only enough cash runway to get it through the second quarter of this year, making for a mad-dash effort to get that drug through clinical trials.

Yahoo | January 25, 2023

Why Is Axcella Health (AXLA) Stock Up 66% Today?

Axcella Health (AXLA) stock is rocketing higher on Tuesday after revealing a regulatory path to registration for AXA1125.

William White on InvestorPlace | January 24, 2023

Why Is LogicMark (LGMK) Stock Down 36% Today?

LogicMark (LGMK) stock is falling on Tuesday after the medical device company priced a $5.2 million public offering of its shares.

William White on InvestorPlace | January 24, 2023

Why Is Novo Integrated Sciences (NVOS) Stock Up 27% Today?

Novo Integrated Sciences (NVOS) stock is taking off on Tuesday despite a lack of news concerning the healthcare company.

William White on InvestorPlace | January 24, 2023

Read More 'AXLA' Stories Here

AXLA Price Returns

1-mo 107.63%
3-mo -33.98%
6-mo -73.02%
1-year -60.23%
3-year -85.95%
5-year N/A
YTD 107.63%
2022 -84.33%
2021 -59.73%
2020 29.43%
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7483 seconds.